Equine p-tau231 antibody and antigen (recombinant protein)
Diagnostic anti-Equine p-tau231 antibodies pairs and antigen for animal health (animal Equine/Horse Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-p-tau231-Ag01 | Recombinant Equine p-tau231 protein | 3090 |
GMP-EQU-p-tau231-Ab01 | Anti-Equine p-tau231 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-p-tau231-Ab02 | Anti-Equine p-tau231 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-p-tau231-Ab03 | Anti-Equine p-tau231 human monoclonal antibody (mAb) | 1953 |
GMP-EQU-p-tau231-Ab04 | Anti-Equine p-tau231 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-p-tau231-Ag01 |
Product Name | Recombinant Equine p-tau231 protein |
Target/Biomarker | Equine Phospho-tau231 (p-tau231) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine Phospho-tau231 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau231 level test of animal Equine/Horse with Alzheimer Disease(AD). |
Tag | His |
Products description | Recombinant Equine p-tau231 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-p-tau231-Ab01, GMP-EQU-p-tau231-Ab02 |
Product Name | Anti-Equine p-tau231 mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine Phospho-tau231 (p-tau231) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine Phospho-tau231 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau231 antibodies in p-tau231 level test of animal Equine/Horse with Alzheimer Disease(AD). |
Tag | mFc |
Products description | Anti-Equine p-tau231 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau231 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-p-tau231-Ab03, GMP-EQU-p-tau231-Ab04 |
Product Name | Anti-Equine p-tau231 human monoclonal antibody (mAb) |
Target/Biomarker | Equine Phospho-tau231 (p-tau231) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine Phospho-tau231 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau231 antibodies in p-tau231 level test of animal Equine/Horse with Alzheimer Disease(AD). |
Tag | hFc |
Products description | Anti-Equine p-tau231 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-p-tau231 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Associated products
- Recommend Pair Antibody and Antigen
- Associated products
Pair Antibody and Antigen | Products detail | Cat.No | Product Name |
P-tau217 | 1. Antigen | 1. GMP-h-p-tau217-Ag01 | Phospho-tau217 (p-tau217) antigen |
2. Capture antibody | 2. GMP-h-p-tau217-Ab01 | Anti-human p-tau217 mouse monoclonal antibody(mAb) | |
3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein | |
P-tau181 | 1. Antigen | 1. GMP-h-p-tau181-Ag01 | Phospho-tau181 (p-tau181) antigen |
2. Capture antibody | 2. GMP-h-p-tau181-Ab01 | Anti-human p-tau181 mouse monoclonal antibody(mAb) | |
3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein | |
P-tau231 | 1. Antigen | 1. GMP-h-p-tau231-Ag01 | Phospho-tau231 (p-tau231) antigen |
2. Capture antibody | 2. GMP-h-p-tau231-Ab01 | Anti-human p-tau231 mouse monoclonal antibody(mAb) | |
3. Detector antibody | 3. GMP-h-Tau-Ab03 | Recombinant human Tau Protein |
Catalog No. | Products Name | Biomarker | Fc/Tag | Products Information |
GMP-h-p-tau202/205-Ab | Anti-human p-tau202 and 205 monoclonal antibody(mAb) | Phospho-tau202 and 205 (p-tau202 and 205) | hFc/mFc | Details |
GMP-h-p-tau212/214-Ab | Anti-human p-tau212 and 214 monoclonal antibody(mAb) | Phospho-tau212 and 214 (p-tau212 and 214) | hFc/mFc | Details |
GMP-h-p-tau413-Ab | Anti-human p-tau413 monoclonal antibody(mAb) | Phospho-tau413 (p-tau413) | hFc/mFc | Details |
GMP-h-p-tau422-Ab | Anti-human p-tau422 monoclonal antibody(mAb) | Phospho-tau422 (p-tau422) | hFc/mFc | Details |
GMP-h-Tau-Ab | Anti-human Tau monoclonal antibody(mAb) | tau proteins (Tau) | hFc/mFc | Details |
Target/Biomarker information
Equine p-tau231, the phosphorylated Tau Protein 231 variant specific to horses, stands as a sentinel within the intricate landscape of equine neurobiology. At its core, it is a Tau protein that has undergone precise phosphorylation at residue 231. Tau proteins, under normal circumstances, play a vital role in stabilizing microtubules within neuronal cells, ensuring proper intracellular transport and the structural integrity of axons. However, in the context of neurodegenerative diseases, the narrative takes a different turn. Phosphorylation events can lead to the misfolding and aggregation of Tau proteins, and equine p-tau231 is no exception. It tends to aggregate and form neurofibrillary tangles within the neural tissues of afflicted horses. These neurofibrillary tangles, reminiscent of those observed in human neurodegenerative diseases like Alzheimer's, serve as a pathological hallmark of various equine neurodegenerative conditions. The accumulation of p-tau231 in neurofibrillary tangles contributes to progressive neuronal dysfunction, ultimately manifesting as clinical signs in conditions such as equine neuroaxonal dystrophy (eNAD) and specific encephalopathies.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.